Covered recipient · General Payments record
MICHAEL W LENIHAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$58,475.14
- Reported across 438 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,780.00 | 3 |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,410.00 | 4 |
| Food and Beverage | $1,911.58 | 54 |
| Travel and Lodging | $1,540.86 | 5 |
| Education | $38.88 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $15,126.92 | 23 |
| UCB, Inc. | $3,415.27 | 7 |
| EMD Serono, Inc. | $196.95 | 3 |
| ABBVIE INC. | $186.26 | 16 |
| Neurelis, Inc. | $171.59 | 6 |
| SK Life Science, Inc. | $166.12 | 3 |
| Amgen Inc. | $141.36 | 3 |
| GENZYME CORPORATION | $124.76 | 1 |
| Lilly USA, LLC | $66.14 | 3 |
| ARGENX US, INC. | $37.06 | 2 |
| Neurocrine BioSciences, Inc. | $28.38 | 1 |
| PFIZER INC. | $20.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (69)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.43 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161560 | CMS |
| ABBVIE INC. | $11.24 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161562 | CMS |
| ABBVIE INC. | $26.13 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161564 | CMS |
| ABBVIE INC. | $5.00 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161566 | CMS |
| ABBVIE INC. | $7.92 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161568 | CMS |
| ABBVIE INC. | $25.13 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161570 | CMS |
| ABBVIE INC. | $13.46 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161572 | CMS |
| ABBVIE INC. | $2.03 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161574 | CMS |
| ABBVIE INC. | $11.10 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161576 | CMS |
| ABBVIE INC. | $14.78 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161578 | CMS |
| ABBVIE INC. | $8.78 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161580 | CMS |
| ABBVIE INC. | $5.46 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161582 | CMS |
| ABBVIE INC. | $18.46 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161584 | CMS |
| ABBVIE INC. | $10.25 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161586 | CMS |
| ABBVIE INC. | $4.53 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161588 | CMS |
| ABBVIE INC. | $12.56 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104161590 | CMS |
| Amgen Inc. | $10.34 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115865241 | CMS |
| Amgen Inc. | $121.13 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117609748 | CMS |
| Amgen Inc. | $9.89 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115865250 | CMS |
| ARGENX US, INC. | $19.24 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142103703 | CMS |
| ARGENX US, INC. | $17.82 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142109965 | CMS |
| Eisai Inc. | $100.00 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765921 | CMS |
| Eisai Inc. | $848.20 | 04/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110765929 | CMS |
| Eisai Inc. | $33.75 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765933 | CMS |
| Eisai Inc. | $299.79 | 04/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110765937 | CMS |
| Eisai Inc. | $25.00 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765923 | CMS |
| Eisai Inc. | $299.79 | 04/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110765925 | CMS |
| Eisai Inc. | $50.00 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765927 | CMS |
| Eisai Inc. | $50.00 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765931 | CMS |
| Eisai Inc. | $25.00 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765935 | CMS |
| Eisai Inc. | $30.00 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765939 | CMS |
| Eisai Inc. | $7,020.00 | 05/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110765951 | CMS |
| Eisai Inc. | $1,470.00 | 06/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110765949 | CMS |
| Eisai Inc. | $18.27 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765941 | CMS |
| Eisai Inc. | $490.00 | 09/18/2024 | Compensation for serving as faculty or as a speaker for a medical education program | Undisputed | 01/23/2026 | 1110765943 | CMS |
| Eisai Inc. | $1,225.00 | 09/18/2024 | Compensation for serving as faculty or as a speaker for a medical education program | Undisputed | 01/23/2026 | 1110765945 | CMS |
| Eisai Inc. | $122.07 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765947 | CMS |
| Eisai Inc. | $95.20 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765919 | CMS |
| Eisai Inc. | $13.89 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765963 | CMS |
| Eisai Inc. | $1,225.00 | 12/11/2024 | Compensation for serving as faculty or as a speaker for a medical education program | Undisputed | 01/23/2026 | 1110765953 | CMS |
| Eisai Inc. | $122.88 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765955 | CMS |
| Eisai Inc. | $1,470.00 | 12/11/2024 | Compensation for serving as faculty or as a speaker for a medical education program | Undisputed | 01/23/2026 | 1110765957 | CMS |
| Eisai Inc. | $10.00 | 12/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110765959 | CMS |
| Eisai Inc. | $83.08 | 12/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110765961 | CMS |
| EMD Serono, Inc. | $98.61 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120214564 | CMS |
| EMD Serono, Inc. | $95.02 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120278110 | CMS |
| EMD Serono, Inc. | $3.32 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120276746 | CMS |
| GENZYME CORPORATION | $124.76 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139634117 | CMS |
| Lilly USA, LLC | $20.54 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135173168 | CMS |
| Lilly USA, LLC | $27.05 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135191961 | CMS |
| Lilly USA, LLC | $18.55 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135200177 | CMS |
| Neurelis, Inc. | $12.96 | 03/11/2024 | Education | Undisputed | 01/23/2026 | 1145646463 | CMS |
| Neurelis, Inc. | $12.96 | 04/15/2024 | Education | Undisputed | 01/23/2026 | 1145646465 | CMS |
| Neurelis, Inc. | $6.53 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145646467 | CMS |
| Neurelis, Inc. | $12.96 | 05/15/2024 | Education | Undisputed | 01/23/2026 | 1145646469 | CMS |
| Neurelis, Inc. | $120.54 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145646471 | CMS |
| Neurelis, Inc. | $5.64 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145646473 | CMS |
| Neurocrine Biosciences, Inc. | $28.38 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150829728 | CMS |
| PFIZER INC. | $20.51 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131646199 | CMS |
| SK Life Science, Inc. | $21.13 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154140252 | CMS |
| SK Life Science, Inc. | $24.79 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154140274 | CMS |
| SK Life Science, Inc. | $120.20 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154140340 | CMS |
| UCB, Inc. | $23.52 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143472005 | CMS |
| UCB, Inc. | $23.54 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143472009 | CMS |
| UCB, Inc. | $7.04 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143472013 | CMS |
| UCB, Inc. | $31.01 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143472018 | CMS |
| UCB, Inc. | $3,290.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143472022 | CMS |
| UCB, Inc. | $27.09 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143472026 | CMS |
| UCB, Inc. | $13.07 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143472031 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.